Get the latest on Amanta Healthcare IPO allotment status, day 3 subscription, GMP updates, and IPO review. Find key details, insights, and investor guidance here.
Table of Contents
Amanta Healthcare IPO Allotment Status, GMP & Review
The Amanta Healthcare IPO has captured significant attention among retail and institutional investors alike. With strong subscription numbers, steady GMP trends, and allotment status now finalized, this IPO stands out in the healthcare sector. In this blog, we’ll cover the Amanta Healthcare IPO allotment status, Day 3 subscription update, GMP performance, and a full Amanta Healthcare IPO review. We’ll also touch on company fundamentals, financial performance, and future growth prospects.
Amanta Healthcare IPO Allotment Status: Latest Update
The Amanta Healthcare IPO allotment status was finalized on September 4, 2025. Investors can now check their allotment through:
- MUFG Intime India (IPO registrar)
- NSE IPO Portal
- BSE IPO Status Page
If you’ve applied, simply use your PAN, application number, or DP/Client ID to know whether shares were allotted to you{1}.
Amanta Healthcare IPO Day 3 Subscription Status
On Day 3, the IPO received a robust subscription of nearly 83 times its issue size. Breakdown of subscriptions included:
- Retail Investors (RIIs) – ~55x subscribed
- Non-Institutional Investors (NIIs) – ~209x subscribed
- Qualified Institutional Buyers (QIBs) – ~36x subscribed
This demand highlights the strong investor confidence in Amanta Healthcare IPO.
Amanta Healthcare IPO GMP Trend
The GMP (Grey Market Premium) for the Amanta Healthcare IPO has been hovering around ₹8–₹8.5. This translates to a 6–7% listing premium over the upper price band of ₹126. Investors are anticipating a potential listing around ₹134–₹136, reflecting moderate but steady upside expectations.
Amanta Healthcare IPO Review
The Amanta Healthcare IPO review shows positive signals:
- High subscription levels show strong market demand.
- Stable GMP indicates healthy listing gains.
- Sector demand: Healthcare and pharma remain strong long-term plays.
For short-term investors, the GMP suggests modest listing profits. For long-term investors, company fundamentals and expansion plans make it worth considering.
Amanta Healthcare Company Overview
Amanta Healthcare is a prominent pharmaceutical and healthcare solutions provider specializing in sterile solutions and injectable products. With a strong manufacturing base and regulatory compliance, the company is positioned to tap into growing domestic and international healthcare demand.
Amanta Healthcare IPO Financial Performance
Financials play a major role in IPO success. The Amanta Healthcare IPO review based on financials shows:
- Revenue Growth: Consistent rise in sales driven by healthcare product demand.
- Profitability: Healthy profit margins compared to peers in the pharma industry.
- Debt Management: Well-balanced capital structure, giving confidence to investors.
Amanta Healthcare IPO Future Growth Prospects
The IPO proceeds are expected to fund capacity expansion, R&D investments, and debt reduction. With the global healthcare sector witnessing rapid growth, Amanta Healthcare IPO offers long-term potential in both domestic and export markets{2}.
IPO Snapshot: Quick Look
| Aspect | Details |
| Price Band | ₹120–₹126 per share |
| GMP | ₹8–₹8.5 (6–7% premium) |
| Subscription Status (Day 3) | ~82.6–83 times |
| Allotment Finalized On | September 4, 2025 |
| Listing Date (Expected) | September 8–9, 2025 |
| Registrar | MUFG Intime India |
How to Check Amanta Healthcare IPO Allotment Status
- Visit MUFG Intime India website → Select IPO → Enter PAN/Application → Submit.
- Visit NSE IPO page → Choose IPO → Enter PAN → Check Status.
- Visit BSE IPO site → Select Equity → Fill in details → Get Status.
Conclusion
The Amanta Healthcare IPO allotment status is finalized, the Day 3 subscription was exceptional, and the GMP points to steady listing gains. Backed by solid financials, healthcare sector demand, and future growth opportunities, the Amanta Healthcare IPO review looks optimistic. While short-term traders may eye GMP-driven gains, long-term investors could benefit from the company’s strong fundamentals.
Frequently Asked Questions
What is Amanta Healthcare IPO allotment status?
The allotment was finalized on September 4, and investors can check it on MUFG Intime, NSE, or BSE websites.
What was Amanta Healthcare IPO Day 3 subscription status?
It was subscribed nearly 83 times, with strong demand from NIIs, RIIs, and QIBs.
What is the GMP for Amanta Healthcare IPO?
The GMP stood around ₹8–₹8.5, suggesting a 6–7% premium over the issue price.
What is the Amanta Healthcare IPO price band?
The price band was set between ₹120–₹126 per share.
When was the Amanta Healthcare IPO allotment finalized?
The allotment status was finalized on September 4, 2025.
When is the Amanta Healthcare IPO listing date?
Listing is expected on September 8 or 9, 2025.
What is the Amanta Healthcare IPO review from experts?
The review is positive due to high subscription, stable GMP, and solid sector outlook.
How to check Amanta Healthcare IPO allotment status online?
You can check via MUFG Intime India, NSE IPO page, or BSE IPO status portal.
What are Amanta Healthcare’s growth prospects?
Strong demand in healthcare, capacity expansion, and R&D investments boost future growth potential.
Should I apply for Amanta Healthcare IPO for listing gains?
Yes, GMP suggests moderate listing gains, but long-term benefits depend on fundamentals and market conditions.
By PaisaInvests
